SlideShare a Scribd company logo
1 of 50
PREGNANCY INDUCED
HYPERTENSION
PATIENT PARTICULARS
• NAME : Mrs Guddan
• AGE : 34 yrs
• HUSBAND'S NAME : Hav Nawab Ali
• ADDRESS : Village- Gheja, Uttar Pradesh
• DATE OF ADMISSION : 02/11/2019
• LMP : 19/02/2019
• EDD : 26/11/2019
• OBSTETRIC SCORE : G3P2L2
• GESTATIONAL SCORE : 36 Weeks 05 Days
• DIAGNOSIS : ANC With Pre-eclampsia with GDM
PRESENTING COMPLAINTS
• Mrs Guddan, a 34 yr old multigravida, known case
of GDM and pre-eclampsia was admitted at 36
weeks 05 days period of gestation for safe
confinement and early termination of pregnancy with
induction of labour planned after completion of 37
weeks period of gestation
PRESENT HISTORY OF ILLNESS
• Known case of GDM and pre-eclampsia, was started of OHA's and insulin therapy
and oral antihypertensives at 31 weeks POG
• Mrs Guddan got admitted to maternity ward on 02/11/2019 for safe confinement and
BP monitoring and early termination of pregnancy after completion of 37 weeks
POG
• Blood sugar and BP monitored throughout her stay- within normal limit
• Induction done at 37 weeks 02 days POG with cerviprime on 07/11/2019 .
PAST MEDICAL/SURGICAL HISTORY OF
ILLNESS
• No known significant medical history
• Fracture humerus(left) operated in 2016
FAMILY HISTORY OF ILLNESS
• No significant medical or surgical history of illness
PERSONAL HISTORY
• NUTRITION
 Dietary Habits : Non Vegetarian
 Meal Pattern : 3 meal pattern
 Smoking : Non Smoker
 Alcohol : Non Alcoholic
• HYGIENE
Patient performs all activities of daily living herself and
was well groomed
PERSONAL HISTORY
• SLEEPING PATTERN
Normal sleeping pattern, slept 1-2 hours in the afternoon and around 6-7
hours at night everyday
• ELIMINATION
No history of constipation. No history of urinary retention or incontinence
PERSONAL HISTORY
• ALLERGIC REACTION
No known history of any allergic reactions
• CONTRACEPTIVE HISTORY
No contraceptives used post marriage
MENSTRUAL HISTORY
• Menarche : 15 years
• Cycle : 28-30 days/ 4-5 days and regular
• LMP :19/02/2019
• EDD :26/11/2019
MARITAL HISTORY
• Patient married at the age of 19 years
• Married since past 12 years
• Had a non consanguineous marriage
OBSTETRIC HISTORY
• PAST OBSTETRIC HISTORY
• PRESENT OBSTETRIC HISTORY
1. 1st TRIMISTER
 Booked case, her first visit at MH Jalandhar was on 13/06/19 at 16 wks 04
days POG
 Vomiting and nausea present during first trimester
SL NO YEAR CONCEPTION PREGANCY OUTCOME PUERPARIUM DETAILS OF
CHILD
1. 2011 Spontaneous Normal Vaginal Delivery Uneventful Male
3.5kg
2. 2012 Spontaneous Normal Vaginal Delivery Uneventful Female
3.5kg
3. 2019 Spontaneous Present Pregnancy
OBSTETRIC HISTORY
2. 2nd TRIMESTER
 Quickening felt at 19 weeks POG
 Two doses of Inj TT taken
3. 3rd TRIMESTER: Presence of GDM and PIH detected
 30 weeks: Derranged blood sugar level, started on OHAs
 31 weeks 02 days: Had raised Blood pressure, admitted for BP and Blood
sugar monitoring to Maternity ward. Started on antihypertensives
 35 weeks : Started on Lispro and Glargin and added Tab Labetatol, due
to persisteantly raised Blood sugars and BP
PHYSICAL EXAMINATION
 VITAL SIGNS:
 Temp : 98.4F
 Pulse : 90/min
 Respiration : 22/min
 BP : 144/90 mmHg
 Nutritional status : Good
 Build : Average
 Height : 164cm
 Weight : 68kg
 BMI : 26.5 kg/m2
CONTINUED
 Pallor : Not present
 Icterus : Not present
 Breast : Enlarged in size, primary and secondary areola
present, montgomery tubercles prominent, no colostrum seen
 Thyroid : Not enlarged
 Pedal edema : Present
 Varicose vein : Not present
 Heart, liver & spleen: NAD
 Lungs : No signs of breathlessness, normal lung sounds
ABDOMINAL EXAMINATION
 INSPECTION
• Size : Appropriate for period of gestation
• Shape : Ovoid
• Contour : Even
• Fetal movements : Visible fetal movements
• Skin : Linea niagra and straie gravidarum
present
• Umbilicus : Slightly protruded
CONTINUED
 PALPATION
• Lie : Longitudinal
• Presentation : Cephalic
• Position : LOA
• Engagement : Not Engaged
• Abdominal Girth : 88 cm
• Fundal Height : 36 cm
 AUSCULTATION
• FSH : 144/min
INVESTIGATIONS
SL NO INVESTIGATIONS PATEINT VALUE NORMAL VALUE REMARKS
1. Hb 11.2 12-16 mg/dl Normal
2. TLC 7600 4000-11000 cumm Normal
3. PLATELET 1,53,000 1.5-3 lakh/cumm Normal
4. S.Bil 0.3 0.1-1 mg/dl Normal
5. SGOT 25 upto 40 Normal
6. SGPT Kit NA upto 40 -
7. Urea 22 10-50 mg/dl Normal
8. Creatinine Kit NA 0.5- 1.4 mg/dl -
9. Uric acid 5.4 <4.5 mg/dl >4.5 indicative of pre-
eclampsia
10. 24 Hours urine protein 325 <300mg Proteinurea
11. PBS for hemolysis NAD No hemolysis Normal
12. LDH 552 200-400 s/o hemolysis
13. Urine for ketones Negative Negative Normal
INVESIGATIONS
SUGAR PROFILE 21/09/19 23/09/19 22/10/19 31/10/19
FASTING
PP
BL
AL
BD
AD
3AM
HBA1C
99mg/dl
115mg/dl
93mg/dl
126mg/dl
156mg/dl
142mg/dl
-
8% (4.5-6.3%)
120mg/dl
111mg/dl
148mg/dl
132mg/dl
143mg/dl
166mg/dl
-
112mg/dl
155mg/dl
93mg/dl
103mg/dl
116mg/dl
158mg/dl
-
90mg/dl
100mg/dl
88mg/dl
104mg/dl
110mg/dl
102mg/dl
95mg/dl
USG at 31 weeks: Gravid uterus showing single live fetus,
Adequate amniotic flow
Placenta posterior, away from the internal os
Normal flow in umbilical artery and maternal uterine arteries
TREATMENT
SNO3. NAME OF DRUG DOSE FREQUENCY TIME
1. TAB METFORMIN 1g BD 7-7
2. TAB LABETALOL 100mg TDS 10-2-10
3. TAB ECOSPRIN 75mg OD 2pm
4. TAB CALCIUM 1 BD 10-10
5. TAB AUTRIN 1 OD 10am
6. INJ LISPRO 6U-6U-6U TDS With meals
7. INJ GLARGIN 6U HS 10pm
INTRAPARTUM MANAGEMENT
• Induction done at 37 weeks 02 days POG with cerviprime on 07/11/2019
cervix- 2cm, Effacement- 20% Head station- -3 , Membranes intact
• Augmented labor with ARM and inj pitocin infusion
• Sugar and BP monitored throughout the period of labour
• Patient gave complaint of uneasiness, BP recorded 150/98mmHg
• At 1730 hours patient had an episode of seizures (GTCS), Inj MgSO4 4g IV stat
administered over 3-5 min and infusion started @1g/hr and oxygen supplemented
via nasal prongs and shifted to OT for emergency LSCS
POST OPERATIVE MANAGEMENT
• Extracted a healthy alive baby
 TOB- 1836 HOURS
 DOB- 07/11/2019
 SEX - Male
 B.wt - 3kg
• Observed closely at ICU for 24 hours, continued on MgSO4 infusion
• Monitored hourly- BP, knee jerk, respiration and urine output
• Started on IV antibiotics
• Shifted to maternity ward after 24 hours
PREGNANCY INDUCED HYEPERTENSION
INCIDENCE
• 3.7% of pregnancies
• 16% of pregnancy related death
• Eclampsia 1 in 2000 deliveries
CLASSIFICATION OF HYPERTENSION IN
PREGNANCY

DISORDER DEFINITION
1. HYPERTENSION
2. GESTATIONAL
HYPERTENSION
3.PRE-ECLAMPSIA
4. ECLAMPSIA
5. CHRONIC
HYPERTENSION
6. SUPERIMPOSED PRE
ECLAMPSIA/ECLAMPSIA
BP ≥ 140/90 mmhg measured 2 times with atleast a 6 hr interval
BP ≥ 140/90 mmhg for the first time in pregnancy after 20 weeks,
without proteinuria
Gestational Hypertension with proteinuria
Women with pre-eclampsia complicated with convulsions
Known hypertension before pregnancy or hypertension diagnosed first time
before 20 weeks of pregnancy
Occurence of new onset of proteinuria in women with chronic hypertension
PRE-ECLAMPSIA
• Multisystem disorder of unknown etiology characteristized by development
of hypertension to the extent of 140/90 mmHg or more with protienuria
after 20 week in a previously normotensive and nonproteinuric women
DIAGNOSTIC CRITERIA
• Hypertension
• Oedema: Pitting edema over the ankles over 12 hours bed rest or rapid
weight gain 0.5 kg a week
• Proteinuria: Presence of total protein in 24 hours urine of more than 0.3g
or ≥ 2+ (1g/L) on atleast two random clean catch urine samples tested ≥ 4
hours apart in the absence of any UTIs
CLINICAL TYPES
• MILD PRE-ECLAMPSIA
 BP ≥ 140/90 mmHg but less than
160/110mmHg without significant
proteinuria
• SEVERE PRE-ECLAMPSIA
 Persistent BP ≥ 160/110 mmHg
 Protein excretion > 5g/24 hrs
 Oliguria <400ml/24 hours
 Platelet < 100,000/mm3
 Cerebral or visual disturbances
ECLAMPSIA
• Pre-eclampsia when complicated with generalized tonic-clonic
convulsions and or coma is called eclampsia
• May appear before, during or after labor
RISK FACTORS
• Primigravida: Young or elderly
• Family history
• Placental abnormalities: excessive
exposure to chorionic villi- molar
pregnancy, multiple pregnancy,
diabetes
• Obesity
• Pre-existing vascular diseases
• Thrombophilias
PATHOPHYSIOLOGY
PATHOPHYSIOLOGY
CLINICAL FEATURES
 Mild symptoms:
• Slight swelling over the ankles
• Gradually extending to the face, abdominal
wall, vulva and even the whole body
 Alarming symptoms:
• Headache
• Disturbed sleep
• Oliguria
• Epigastric pain
• Blurring/dimness of vision
SIGNS
• Weight gain
• Persistent rise of BP > 140/90mmHg
• Edema over ankles
• Pulmonary edema
• Abdominal examination: scanty liqour or IUGR (chronic placental
insufficiency)
• Eclamptic Fit or Convulsions
 PREMONITORY STAGE
 TONIC STAGE
 CLONIC STAGE
 STAGE OF COMA
INVESTIGATIONS
• Urine: Proteinuria is the last feature of pre-eclampsia to
occur
• Ophthalmic examination: Retinal edema, constriction of
the arterioles,hemorrhage etc
• Blood values: Serum uric acid >4.5 mg/dL
 Serum creatinine maybe >1mg/dL,
 Urea normal to slightly raised,
 Thrombocytopenia,
 Abnormal coagulation profile and
 Hepatic enzymes maybe elevated
COMPLICATIONS
• IMMEDIATE: MATERNAL
• ECLAMPSIA: Injuries, pulmonary failure, neurological deficits, cardiac and renal
shutdown, coagulopathies, postpartum psychosis
DURING PREGNANCY DURING LABOR PUERPERIUM
a. Eclampsia
b. Antepartum hemorrhage
c. Acute renal failure
d. Cardiac failure
e. Dimness of vision or even
blindness
f. Preterm labor
g. HELLP Syndrome
h. ARDS
a. Eclampsia
b. Postpartum hemorrhage
a. Eclampsia
b. Shock
c. Sepsis
COMPLICATIONS
• IMMEDIATE: FETAL
a. Intrauterine fetal death
b. Intrauterine growth retardation
c. Asphyxia
d. Prematurity
• REMOTE: MATERNAL
a. Residual hypertendion
b. Recurrent pre-eclampsia
c. Chronic renal disease
d. Risk of palental abruption
PREVENTION
• Regular antenatal checkup
• Antithrombotic agents: Tab Ecosprin 75mg daily in
potentially high risk patients
• Heparin or Low Molecular Weight Heparin is useful in
women with thrombophilia and with high risk
pregnancy
• Calcium supplementation 2gm per day
• Antioxidants: Vitamin E and C
• Balanced diet rich in protein
MANAGEMENT
• HOSPITAL MANAGEMENT
i. Rest
ii. Continuous BP monitoring - every 4 Hourly
iii. Blood investigations: Platelet, coagulation profile, uric acid, creatinine,
LFT and 24 hour urine protein
iv. Daily urine dipstick
v. Ophthalmoscopy
vi. Fetal well being assessment: DFMC, NST, CTG, Biophysical profile and
USG-Doppler
vii. Antihypertensives: Diastolic BP over 110mmHg
MANAGEMENT
ANTIHYPERTENSIVES
DRUG DOSE SCHEDULE MAXIMUM DOSE
 Tab Labetalol
 Tab Nifedipine
 Tab Methydopa
 Tab Hydralazine
100mg qid
10-20 mg bd
250-500mg tds or qid
10-25 mg bd
HYPERTENSIVE CRISIS- BP ≥160/110 mmHg or MAP ≥ 125 mmHg
 Inj Labetalol
 Inj Hydralazine
 Tab Nifedipine
 Inj NTG
 Inj Sodium nitropruside
10-20 mg IV/10 min
5mg/30 min
10-20 mg oral, can be repeated
in 30 min
5µg/min IV
0.25-5µg/kg/min IV
300mg
30 mg
240 mg/24 hrs
} Only used when other drugs
have failed
MANAGEMENT
COMPLETE CONTROL BP PERSISTENTLY
HIGH
PERSISTENTLY ↑BP
EVEN WITH ANTI-
HYPERTENSIVES
ADDITIONAL
OMNIOUS SYMPTOMS
• PRETERM: Discharge
and attend ANC Clinic
• TERM: Hospitalization
≥ 37 weeks then
deliver
Try to continue
pregnancy till 37 weeks
or atleast 34 weeks then
deliver
• Couple counseling
• Transfer to tertiary care center
• Prophylactic anticonvulsant therapy
• Delivery, irrespective of POG
• Steroid if < 34 weeks
METHOD OF DELIVERY
 Induction of labour
 Cesarean
MANAGMENT: ECLAMPSIA
• Maintain: airway, breathing and
circulation
• Oxygen administration 8-10 l/min
• Arrest convulsions
• Ventilatory support (if needed)
• Prevention of injuries
• Hemodynamic stabilization
• Organize investigations
• Deliver by 6-8 hours
• Prevention of complications
• Postpartum care
MANAGMENT: ECLAMPSIA
FIRST AID OUTSIDE THE HOSPITAL MEDICAL and NURSING MANAGEMENT
• Shift to tertiary cary hospital immediately
• All maternal documents
• Stabilize BP, arrest convulsions
• MgSO4 : Pritchard/Zuspan
• Inj Labetalol 20 mg IV
• Diuretics: Pulmonary edema
• Diazepam 5 mg: Avoid apnoe or cardiac
arrest
• Trained medical personnel or a midwife
• Supportive care: Management during fits
• Detailed history
• Examination: General, abdominal and vaginal
examination
• Monitoring: Half hourly-pulse, respiration and
BP
hourly- Urine output
• Fluid balance: Total fluid previous UO +
1000ml (RL)
• Antibiotics: In Ceftriaxone 1g BD
MANAGMENT: ECLAMPSIA
• MANAGEMENT DURING FITS:
 Placed in a railed cot, mouth gag to be placed in premonitory stage
 Lateral decubitus position
 Clear air passage to avoid aspiration
 Oxygen 8-10 l/min
 Continous monitoring
 ABG if oxygen saturation < 92%
 STATUS EPILEPTICUS: Inj Thiopentone sodium 0.5 g dissolved in 20
ml 5%D IV slow
Anesthesia, muscle relaxants and assisted ventilation
ANTICONVULSANT AND SEDATIVE
REGIMEN LOADING DOSE MAINTENANCE DOSE
INTRAMUSCULAR
(PRITCHARD)
4g IV, over 3-5 min followed by
10g deep IM (5g in each buttock)
5g IM 4 hours in alt buttock
INTRAVENOUS (ZUSPAN OR
SIBAI)
4-6g IV over 15-20 min 1-2g/hr IV infusion
Recurret fits: 2g repeat IV bolus over 5 min in the above regimen
MANAGEMENT: ECLAMSIA
 ECLAMPSIA : IN LABOR
• ARM: Forceps, ventose
• Cesarean: Uncontrolled fits, unconscious patient with poor prospect of
vaginal delivery, malpresentations
• ECLAMPSIA: NOT IN LABOR
FITS CONTROLLED FITS NOT CONTROLLED (6-8 HOURS)
• Term: Deliver- Induce or CS
• Preterm: Steroid then deliver
• Dead: Induce and deliver
Deliver
• Favourable vaginal findings: ARM, oxytocin
• Unfavourable finding: CS
NURSING MANAGEMENT: ASSESSMENT
• Early prediction and prevention: Look for
omnious signs and symptoms
• Intensive monitoring of the patient
i. Continuous fetal monitoring
ii.Assess vital signs
• Ask patient to tell if she develops a
headache, blurred vision, dizziness or
epigastric pain
• Age and parity
• Predisposing factors
NURSING DIAGNOSIS
• Altered tissue perfusion related to decreased uteroplacental perfusion,
maternal hypovolemia
• Fluid volume deficit related to decreasing plasma colloid and ongoing
renal shutdown
• Decreased cardiac output related to hpovolemis/decreased venous return
and increased systemic vascular resistenace
• Ineffective airway clearance related to possible chances of aspiration due
to convulsions
• Risk for maternal injury related to tonic clonic convulsions
• Impaired physical mobility related to decreased muscle strength
• Risk for fetal injury
• Risk for infections
NURSING INTERVENTION
• Faciliate early prenatal care
• Assess physical parameters
• Provide diet instructions
• Instruct regarding medications
• Anticipate seizure:Prompt seizure prophylaxsis
• Maintain IV assess, catheterize the patient
• Special considerations during MgSO4 infusion: Continue infusion only if
Knee jerks are present, Urine output is >30ml/hr and RR is >12/min
• Therapeutic serum magnesium level is 4-7mEQ/L
• Administer Inj calcium gluconate for MgSO4 toxicity
• Prepare for labour induction or cesarean
• Continue MgSO4 for 24 hours after delivery
HEALTH EDUCATION
• Regular antenatal checkup
• Drug compliance
• Dietary changes: High protein diet
• Teach and patient about the alarming signs of PIH
• Seek care immediately
• Counselling: Possible early termination of pregnancy, premature new born
• Family support
SUMMARY
• Mrs Guddan, 34 year old multigravida, known case of pre-
eclampsia with GDM got admitted to MH JRC at 36 weeks 06
days POG for safe confinement and induction of labor at 37
weeks POG. During labor after induction as planned, she
developed eclampsia, immediate care was given and shifted
for emergency LSCS. Postpartum continued to have ↑BP.
She was diagnosed as a case of Chronic Hypertension and
was diacharged after 10 days on Tab Amlodipine 5mg OD
Presentation on pregnancy Induced hypertension

More Related Content

Similar to Presentation on pregnancy Induced hypertension

highriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptxhighriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptx
Subi Babu
 
highriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdfhighriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdf
ahmedkhan266631
 
The-Infant-of-a-Diabetic-Mother-81.ppt
The-Infant-of-a-Diabetic-Mother-81.pptThe-Infant-of-a-Diabetic-Mother-81.ppt
The-Infant-of-a-Diabetic-Mother-81.ppt
Shilpa Joshi
 

Similar to Presentation on pregnancy Induced hypertension (20)

OBSTRUCTED LABOR MANAGEMENT.pptx
OBSTRUCTED LABOR MANAGEMENT.pptxOBSTRUCTED LABOR MANAGEMENT.pptx
OBSTRUCTED LABOR MANAGEMENT.pptx
 
UHS CASE PRESENTATION, MEDICAL COLLEGE P
UHS CASE PRESENTATION, MEDICAL COLLEGE PUHS CASE PRESENTATION, MEDICAL COLLEGE P
UHS CASE PRESENTATION, MEDICAL COLLEGE P
 
A Case of Primigravida with 36 weeks of pregnancy with IUD with obstructed la...
A Case of Primigravida with 36 weeks of pregnancy with IUD with obstructed la...A Case of Primigravida with 36 weeks of pregnancy with IUD with obstructed la...
A Case of Primigravida with 36 weeks of pregnancy with IUD with obstructed la...
 
death meeting liver disease edited.pptx
death meeting  liver disease edited.pptxdeath meeting  liver disease edited.pptx
death meeting liver disease edited.pptx
 
highriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptxhighriskpregnancy-190711111446 (1).pptx
highriskpregnancy-190711111446 (1).pptx
 
Case presentation on Neonatal Apnea
Case presentation on Neonatal ApneaCase presentation on Neonatal Apnea
Case presentation on Neonatal Apnea
 
TEF PPT
TEF PPTTEF PPT
TEF PPT
 
Evaluation and management of hypertension in pregnancy
Evaluation and management of hypertension in pregnancyEvaluation and management of hypertension in pregnancy
Evaluation and management of hypertension in pregnancy
 
OBS AND GYNAE APH case presentation
OBS AND GYNAE APH case presentationOBS AND GYNAE APH case presentation
OBS AND GYNAE APH case presentation
 
Pregnancy Induced Hypertension
Pregnancy Induced Hypertension Pregnancy Induced Hypertension
Pregnancy Induced Hypertension
 
High risk infant new
High risk infant newHigh risk infant new
High risk infant new
 
Downs + pneum
Downs + pneumDowns + pneum
Downs + pneum
 
Downs + pneum
Downs + pneumDowns + pneum
Downs + pneum
 
placental mesenchymal dysplasia pptx
placental mesenchymal dysplasia pptxplacental mesenchymal dysplasia pptx
placental mesenchymal dysplasia pptx
 
highriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdfhighriskpregnancy-190711111446.pdf
highriskpregnancy-190711111446.pdf
 
High risk pregnancy
High risk pregnancyHigh risk pregnancy
High risk pregnancy
 
IUD.pptx
IUD.pptxIUD.pptx
IUD.pptx
 
Antenatal haemorrhage
Antenatal haemorrhageAntenatal haemorrhage
Antenatal haemorrhage
 
madc.pptx
madc.pptxmadc.pptx
madc.pptx
 
The-Infant-of-a-Diabetic-Mother-81.ppt
The-Infant-of-a-Diabetic-Mother-81.pptThe-Infant-of-a-Diabetic-Mother-81.ppt
The-Infant-of-a-Diabetic-Mother-81.ppt
 

More from FEMIFRANCIS5 (10)

ASV PROTOCOL PPT WHO guidelines and management
ASV PROTOCOL PPT WHO guidelines and managementASV PROTOCOL PPT WHO guidelines and management
ASV PROTOCOL PPT WHO guidelines and management
 
Stress Management(1).ppt..care of patient with anxiety
Stress Management(1).ppt..care of patient with anxietyStress Management(1).ppt..care of patient with anxiety
Stress Management(1).ppt..care of patient with anxiety
 
Antenatal-care-Nadim-for-undergraduates.ppt
Antenatal-care-Nadim-for-undergraduates.pptAntenatal-care-Nadim-for-undergraduates.ppt
Antenatal-care-Nadim-for-undergraduates.ppt
 
BASIC FORMAT ~ FE03-1.pdf
BASIC FORMAT ~ FE03-1.pdfBASIC FORMAT ~ FE03-1.pdf
BASIC FORMAT ~ FE03-1.pdf
 
Diabetes mellitus.pptx
Diabetes mellitus.pptxDiabetes mellitus.pptx
Diabetes mellitus.pptx
 
mns history & growth.pptx
mns history & growth.pptxmns history & growth.pptx
mns history & growth.pptx
 
Protocols for patient care.pptx
Protocols for patient care.pptxProtocols for patient care.pptx
Protocols for patient care.pptx
 
HOSPITAL DIETARY SERVICES latest 1.ppt
HOSPITAL DIETARY SERVICES latest 1.pptHOSPITAL DIETARY SERVICES latest 1.ppt
HOSPITAL DIETARY SERVICES latest 1.ppt
 
Perioperative Nursing 1.pptx
Perioperative Nursing 1.pptxPerioperative Nursing 1.pptx
Perioperative Nursing 1.pptx
 
MECHANICAL VENTILATION.pptx
MECHANICAL VENTILATION.pptxMECHANICAL VENTILATION.pptx
MECHANICAL VENTILATION.pptx
 

Recently uploaded

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 

Recently uploaded (20)

Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 

Presentation on pregnancy Induced hypertension

  • 2. PATIENT PARTICULARS • NAME : Mrs Guddan • AGE : 34 yrs • HUSBAND'S NAME : Hav Nawab Ali • ADDRESS : Village- Gheja, Uttar Pradesh • DATE OF ADMISSION : 02/11/2019 • LMP : 19/02/2019 • EDD : 26/11/2019 • OBSTETRIC SCORE : G3P2L2 • GESTATIONAL SCORE : 36 Weeks 05 Days • DIAGNOSIS : ANC With Pre-eclampsia with GDM
  • 3. PRESENTING COMPLAINTS • Mrs Guddan, a 34 yr old multigravida, known case of GDM and pre-eclampsia was admitted at 36 weeks 05 days period of gestation for safe confinement and early termination of pregnancy with induction of labour planned after completion of 37 weeks period of gestation
  • 4. PRESENT HISTORY OF ILLNESS • Known case of GDM and pre-eclampsia, was started of OHA's and insulin therapy and oral antihypertensives at 31 weeks POG • Mrs Guddan got admitted to maternity ward on 02/11/2019 for safe confinement and BP monitoring and early termination of pregnancy after completion of 37 weeks POG • Blood sugar and BP monitored throughout her stay- within normal limit • Induction done at 37 weeks 02 days POG with cerviprime on 07/11/2019 .
  • 5. PAST MEDICAL/SURGICAL HISTORY OF ILLNESS • No known significant medical history • Fracture humerus(left) operated in 2016 FAMILY HISTORY OF ILLNESS • No significant medical or surgical history of illness
  • 6. PERSONAL HISTORY • NUTRITION  Dietary Habits : Non Vegetarian  Meal Pattern : 3 meal pattern  Smoking : Non Smoker  Alcohol : Non Alcoholic • HYGIENE Patient performs all activities of daily living herself and was well groomed
  • 7. PERSONAL HISTORY • SLEEPING PATTERN Normal sleeping pattern, slept 1-2 hours in the afternoon and around 6-7 hours at night everyday • ELIMINATION No history of constipation. No history of urinary retention or incontinence
  • 8. PERSONAL HISTORY • ALLERGIC REACTION No known history of any allergic reactions • CONTRACEPTIVE HISTORY No contraceptives used post marriage
  • 9. MENSTRUAL HISTORY • Menarche : 15 years • Cycle : 28-30 days/ 4-5 days and regular • LMP :19/02/2019 • EDD :26/11/2019 MARITAL HISTORY • Patient married at the age of 19 years • Married since past 12 years • Had a non consanguineous marriage
  • 10. OBSTETRIC HISTORY • PAST OBSTETRIC HISTORY • PRESENT OBSTETRIC HISTORY 1. 1st TRIMISTER  Booked case, her first visit at MH Jalandhar was on 13/06/19 at 16 wks 04 days POG  Vomiting and nausea present during first trimester SL NO YEAR CONCEPTION PREGANCY OUTCOME PUERPARIUM DETAILS OF CHILD 1. 2011 Spontaneous Normal Vaginal Delivery Uneventful Male 3.5kg 2. 2012 Spontaneous Normal Vaginal Delivery Uneventful Female 3.5kg 3. 2019 Spontaneous Present Pregnancy
  • 11. OBSTETRIC HISTORY 2. 2nd TRIMESTER  Quickening felt at 19 weeks POG  Two doses of Inj TT taken 3. 3rd TRIMESTER: Presence of GDM and PIH detected  30 weeks: Derranged blood sugar level, started on OHAs  31 weeks 02 days: Had raised Blood pressure, admitted for BP and Blood sugar monitoring to Maternity ward. Started on antihypertensives  35 weeks : Started on Lispro and Glargin and added Tab Labetatol, due to persisteantly raised Blood sugars and BP
  • 12. PHYSICAL EXAMINATION  VITAL SIGNS:  Temp : 98.4F  Pulse : 90/min  Respiration : 22/min  BP : 144/90 mmHg  Nutritional status : Good  Build : Average  Height : 164cm  Weight : 68kg  BMI : 26.5 kg/m2
  • 13. CONTINUED  Pallor : Not present  Icterus : Not present  Breast : Enlarged in size, primary and secondary areola present, montgomery tubercles prominent, no colostrum seen  Thyroid : Not enlarged  Pedal edema : Present  Varicose vein : Not present  Heart, liver & spleen: NAD  Lungs : No signs of breathlessness, normal lung sounds
  • 14. ABDOMINAL EXAMINATION  INSPECTION • Size : Appropriate for period of gestation • Shape : Ovoid • Contour : Even • Fetal movements : Visible fetal movements • Skin : Linea niagra and straie gravidarum present • Umbilicus : Slightly protruded
  • 15. CONTINUED  PALPATION • Lie : Longitudinal • Presentation : Cephalic • Position : LOA • Engagement : Not Engaged • Abdominal Girth : 88 cm • Fundal Height : 36 cm  AUSCULTATION • FSH : 144/min
  • 16. INVESTIGATIONS SL NO INVESTIGATIONS PATEINT VALUE NORMAL VALUE REMARKS 1. Hb 11.2 12-16 mg/dl Normal 2. TLC 7600 4000-11000 cumm Normal 3. PLATELET 1,53,000 1.5-3 lakh/cumm Normal 4. S.Bil 0.3 0.1-1 mg/dl Normal 5. SGOT 25 upto 40 Normal 6. SGPT Kit NA upto 40 - 7. Urea 22 10-50 mg/dl Normal 8. Creatinine Kit NA 0.5- 1.4 mg/dl - 9. Uric acid 5.4 <4.5 mg/dl >4.5 indicative of pre- eclampsia 10. 24 Hours urine protein 325 <300mg Proteinurea 11. PBS for hemolysis NAD No hemolysis Normal 12. LDH 552 200-400 s/o hemolysis 13. Urine for ketones Negative Negative Normal
  • 17. INVESIGATIONS SUGAR PROFILE 21/09/19 23/09/19 22/10/19 31/10/19 FASTING PP BL AL BD AD 3AM HBA1C 99mg/dl 115mg/dl 93mg/dl 126mg/dl 156mg/dl 142mg/dl - 8% (4.5-6.3%) 120mg/dl 111mg/dl 148mg/dl 132mg/dl 143mg/dl 166mg/dl - 112mg/dl 155mg/dl 93mg/dl 103mg/dl 116mg/dl 158mg/dl - 90mg/dl 100mg/dl 88mg/dl 104mg/dl 110mg/dl 102mg/dl 95mg/dl USG at 31 weeks: Gravid uterus showing single live fetus, Adequate amniotic flow Placenta posterior, away from the internal os Normal flow in umbilical artery and maternal uterine arteries
  • 18. TREATMENT SNO3. NAME OF DRUG DOSE FREQUENCY TIME 1. TAB METFORMIN 1g BD 7-7 2. TAB LABETALOL 100mg TDS 10-2-10 3. TAB ECOSPRIN 75mg OD 2pm 4. TAB CALCIUM 1 BD 10-10 5. TAB AUTRIN 1 OD 10am 6. INJ LISPRO 6U-6U-6U TDS With meals 7. INJ GLARGIN 6U HS 10pm
  • 19. INTRAPARTUM MANAGEMENT • Induction done at 37 weeks 02 days POG with cerviprime on 07/11/2019 cervix- 2cm, Effacement- 20% Head station- -3 , Membranes intact • Augmented labor with ARM and inj pitocin infusion • Sugar and BP monitored throughout the period of labour • Patient gave complaint of uneasiness, BP recorded 150/98mmHg • At 1730 hours patient had an episode of seizures (GTCS), Inj MgSO4 4g IV stat administered over 3-5 min and infusion started @1g/hr and oxygen supplemented via nasal prongs and shifted to OT for emergency LSCS
  • 20. POST OPERATIVE MANAGEMENT • Extracted a healthy alive baby  TOB- 1836 HOURS  DOB- 07/11/2019  SEX - Male  B.wt - 3kg • Observed closely at ICU for 24 hours, continued on MgSO4 infusion • Monitored hourly- BP, knee jerk, respiration and urine output • Started on IV antibiotics • Shifted to maternity ward after 24 hours
  • 22. INCIDENCE • 3.7% of pregnancies • 16% of pregnancy related death • Eclampsia 1 in 2000 deliveries
  • 23. CLASSIFICATION OF HYPERTENSION IN PREGNANCY  DISORDER DEFINITION 1. HYPERTENSION 2. GESTATIONAL HYPERTENSION 3.PRE-ECLAMPSIA 4. ECLAMPSIA 5. CHRONIC HYPERTENSION 6. SUPERIMPOSED PRE ECLAMPSIA/ECLAMPSIA BP ≥ 140/90 mmhg measured 2 times with atleast a 6 hr interval BP ≥ 140/90 mmhg for the first time in pregnancy after 20 weeks, without proteinuria Gestational Hypertension with proteinuria Women with pre-eclampsia complicated with convulsions Known hypertension before pregnancy or hypertension diagnosed first time before 20 weeks of pregnancy Occurence of new onset of proteinuria in women with chronic hypertension
  • 24. PRE-ECLAMPSIA • Multisystem disorder of unknown etiology characteristized by development of hypertension to the extent of 140/90 mmHg or more with protienuria after 20 week in a previously normotensive and nonproteinuric women DIAGNOSTIC CRITERIA • Hypertension • Oedema: Pitting edema over the ankles over 12 hours bed rest or rapid weight gain 0.5 kg a week • Proteinuria: Presence of total protein in 24 hours urine of more than 0.3g or ≥ 2+ (1g/L) on atleast two random clean catch urine samples tested ≥ 4 hours apart in the absence of any UTIs
  • 25. CLINICAL TYPES • MILD PRE-ECLAMPSIA  BP ≥ 140/90 mmHg but less than 160/110mmHg without significant proteinuria • SEVERE PRE-ECLAMPSIA  Persistent BP ≥ 160/110 mmHg  Protein excretion > 5g/24 hrs  Oliguria <400ml/24 hours  Platelet < 100,000/mm3  Cerebral or visual disturbances
  • 26. ECLAMPSIA • Pre-eclampsia when complicated with generalized tonic-clonic convulsions and or coma is called eclampsia • May appear before, during or after labor
  • 27. RISK FACTORS • Primigravida: Young or elderly • Family history • Placental abnormalities: excessive exposure to chorionic villi- molar pregnancy, multiple pregnancy, diabetes • Obesity • Pre-existing vascular diseases • Thrombophilias
  • 29.
  • 31. CLINICAL FEATURES  Mild symptoms: • Slight swelling over the ankles • Gradually extending to the face, abdominal wall, vulva and even the whole body  Alarming symptoms: • Headache • Disturbed sleep • Oliguria • Epigastric pain • Blurring/dimness of vision
  • 32. SIGNS • Weight gain • Persistent rise of BP > 140/90mmHg • Edema over ankles • Pulmonary edema • Abdominal examination: scanty liqour or IUGR (chronic placental insufficiency) • Eclamptic Fit or Convulsions  PREMONITORY STAGE  TONIC STAGE  CLONIC STAGE  STAGE OF COMA
  • 33. INVESTIGATIONS • Urine: Proteinuria is the last feature of pre-eclampsia to occur • Ophthalmic examination: Retinal edema, constriction of the arterioles,hemorrhage etc • Blood values: Serum uric acid >4.5 mg/dL  Serum creatinine maybe >1mg/dL,  Urea normal to slightly raised,  Thrombocytopenia,  Abnormal coagulation profile and  Hepatic enzymes maybe elevated
  • 34. COMPLICATIONS • IMMEDIATE: MATERNAL • ECLAMPSIA: Injuries, pulmonary failure, neurological deficits, cardiac and renal shutdown, coagulopathies, postpartum psychosis DURING PREGNANCY DURING LABOR PUERPERIUM a. Eclampsia b. Antepartum hemorrhage c. Acute renal failure d. Cardiac failure e. Dimness of vision or even blindness f. Preterm labor g. HELLP Syndrome h. ARDS a. Eclampsia b. Postpartum hemorrhage a. Eclampsia b. Shock c. Sepsis
  • 35. COMPLICATIONS • IMMEDIATE: FETAL a. Intrauterine fetal death b. Intrauterine growth retardation c. Asphyxia d. Prematurity • REMOTE: MATERNAL a. Residual hypertendion b. Recurrent pre-eclampsia c. Chronic renal disease d. Risk of palental abruption
  • 36. PREVENTION • Regular antenatal checkup • Antithrombotic agents: Tab Ecosprin 75mg daily in potentially high risk patients • Heparin or Low Molecular Weight Heparin is useful in women with thrombophilia and with high risk pregnancy • Calcium supplementation 2gm per day • Antioxidants: Vitamin E and C • Balanced diet rich in protein
  • 37. MANAGEMENT • HOSPITAL MANAGEMENT i. Rest ii. Continuous BP monitoring - every 4 Hourly iii. Blood investigations: Platelet, coagulation profile, uric acid, creatinine, LFT and 24 hour urine protein iv. Daily urine dipstick v. Ophthalmoscopy vi. Fetal well being assessment: DFMC, NST, CTG, Biophysical profile and USG-Doppler vii. Antihypertensives: Diastolic BP over 110mmHg
  • 38. MANAGEMENT ANTIHYPERTENSIVES DRUG DOSE SCHEDULE MAXIMUM DOSE  Tab Labetalol  Tab Nifedipine  Tab Methydopa  Tab Hydralazine 100mg qid 10-20 mg bd 250-500mg tds or qid 10-25 mg bd HYPERTENSIVE CRISIS- BP ≥160/110 mmHg or MAP ≥ 125 mmHg  Inj Labetalol  Inj Hydralazine  Tab Nifedipine  Inj NTG  Inj Sodium nitropruside 10-20 mg IV/10 min 5mg/30 min 10-20 mg oral, can be repeated in 30 min 5µg/min IV 0.25-5µg/kg/min IV 300mg 30 mg 240 mg/24 hrs } Only used when other drugs have failed
  • 39. MANAGEMENT COMPLETE CONTROL BP PERSISTENTLY HIGH PERSISTENTLY ↑BP EVEN WITH ANTI- HYPERTENSIVES ADDITIONAL OMNIOUS SYMPTOMS • PRETERM: Discharge and attend ANC Clinic • TERM: Hospitalization ≥ 37 weeks then deliver Try to continue pregnancy till 37 weeks or atleast 34 weeks then deliver • Couple counseling • Transfer to tertiary care center • Prophylactic anticonvulsant therapy • Delivery, irrespective of POG • Steroid if < 34 weeks METHOD OF DELIVERY  Induction of labour  Cesarean
  • 40. MANAGMENT: ECLAMPSIA • Maintain: airway, breathing and circulation • Oxygen administration 8-10 l/min • Arrest convulsions • Ventilatory support (if needed) • Prevention of injuries • Hemodynamic stabilization • Organize investigations • Deliver by 6-8 hours • Prevention of complications • Postpartum care
  • 41. MANAGMENT: ECLAMPSIA FIRST AID OUTSIDE THE HOSPITAL MEDICAL and NURSING MANAGEMENT • Shift to tertiary cary hospital immediately • All maternal documents • Stabilize BP, arrest convulsions • MgSO4 : Pritchard/Zuspan • Inj Labetalol 20 mg IV • Diuretics: Pulmonary edema • Diazepam 5 mg: Avoid apnoe or cardiac arrest • Trained medical personnel or a midwife • Supportive care: Management during fits • Detailed history • Examination: General, abdominal and vaginal examination • Monitoring: Half hourly-pulse, respiration and BP hourly- Urine output • Fluid balance: Total fluid previous UO + 1000ml (RL) • Antibiotics: In Ceftriaxone 1g BD
  • 42. MANAGMENT: ECLAMPSIA • MANAGEMENT DURING FITS:  Placed in a railed cot, mouth gag to be placed in premonitory stage  Lateral decubitus position  Clear air passage to avoid aspiration  Oxygen 8-10 l/min  Continous monitoring  ABG if oxygen saturation < 92%  STATUS EPILEPTICUS: Inj Thiopentone sodium 0.5 g dissolved in 20 ml 5%D IV slow Anesthesia, muscle relaxants and assisted ventilation
  • 43. ANTICONVULSANT AND SEDATIVE REGIMEN LOADING DOSE MAINTENANCE DOSE INTRAMUSCULAR (PRITCHARD) 4g IV, over 3-5 min followed by 10g deep IM (5g in each buttock) 5g IM 4 hours in alt buttock INTRAVENOUS (ZUSPAN OR SIBAI) 4-6g IV over 15-20 min 1-2g/hr IV infusion Recurret fits: 2g repeat IV bolus over 5 min in the above regimen
  • 44. MANAGEMENT: ECLAMSIA  ECLAMPSIA : IN LABOR • ARM: Forceps, ventose • Cesarean: Uncontrolled fits, unconscious patient with poor prospect of vaginal delivery, malpresentations • ECLAMPSIA: NOT IN LABOR FITS CONTROLLED FITS NOT CONTROLLED (6-8 HOURS) • Term: Deliver- Induce or CS • Preterm: Steroid then deliver • Dead: Induce and deliver Deliver • Favourable vaginal findings: ARM, oxytocin • Unfavourable finding: CS
  • 45. NURSING MANAGEMENT: ASSESSMENT • Early prediction and prevention: Look for omnious signs and symptoms • Intensive monitoring of the patient i. Continuous fetal monitoring ii.Assess vital signs • Ask patient to tell if she develops a headache, blurred vision, dizziness or epigastric pain • Age and parity • Predisposing factors
  • 46. NURSING DIAGNOSIS • Altered tissue perfusion related to decreased uteroplacental perfusion, maternal hypovolemia • Fluid volume deficit related to decreasing plasma colloid and ongoing renal shutdown • Decreased cardiac output related to hpovolemis/decreased venous return and increased systemic vascular resistenace • Ineffective airway clearance related to possible chances of aspiration due to convulsions • Risk for maternal injury related to tonic clonic convulsions • Impaired physical mobility related to decreased muscle strength • Risk for fetal injury • Risk for infections
  • 47. NURSING INTERVENTION • Faciliate early prenatal care • Assess physical parameters • Provide diet instructions • Instruct regarding medications • Anticipate seizure:Prompt seizure prophylaxsis • Maintain IV assess, catheterize the patient • Special considerations during MgSO4 infusion: Continue infusion only if Knee jerks are present, Urine output is >30ml/hr and RR is >12/min • Therapeutic serum magnesium level is 4-7mEQ/L • Administer Inj calcium gluconate for MgSO4 toxicity • Prepare for labour induction or cesarean • Continue MgSO4 for 24 hours after delivery
  • 48. HEALTH EDUCATION • Regular antenatal checkup • Drug compliance • Dietary changes: High protein diet • Teach and patient about the alarming signs of PIH • Seek care immediately • Counselling: Possible early termination of pregnancy, premature new born • Family support
  • 49. SUMMARY • Mrs Guddan, 34 year old multigravida, known case of pre- eclampsia with GDM got admitted to MH JRC at 36 weeks 06 days POG for safe confinement and induction of labor at 37 weeks POG. During labor after induction as planned, she developed eclampsia, immediate care was given and shifted for emergency LSCS. Postpartum continued to have ↑BP. She was diagnosed as a case of Chronic Hypertension and was diacharged after 10 days on Tab Amlodipine 5mg OD